Literature DB >> 8252689

Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events.

N R Phillips1, D Waters, R J Havel.   

Abstract

BACKGROUND: There is considerable evidence that remnants of triglyceride-rich lipoproteins may be particularly atherogenic. METHODS AND
RESULTS: Levels of lipoprotein lipids and of apolipoprotein B in low-density lipoproteins were measured in 335 men and women enrolled in a study in which quantitative coronary angiography was carried out at 2-year intervals. Clinical events related to coronary disease occurred in 129 patients during the trial and in the subsequent follow-up period of 4 to 6 years. In multivariate analysis controlled for a number of nonlipid risk factors, high-density lipoprotein cholesterol was inversely related to the mean percentage increase in coronary artery stenosis in both men and women. Neither plasma triglycerides nor low-density lipoprotein cholesterol, triglycerides, or apolipoprotein B was related to change in stenosis, but a measure of remnants of triglyceride-rich lipoproteins, which included cholesterol in intermediate-density lipoproteins, was directly related to lesion progression. The same relations for these measures of plasma lipoprotein concentrations were found to hold for clinical events related to coronary artery atherosclerosis.
CONCLUSIONS: In patients with established coronary heart disease, increased levels of remnants of triglyceride-rich lipoproteins and decreased levels of high-density lipoproteins appear to promote progression of coronary artery atherosclerosis, which in turn may lead to an untoward clinical event. No such relation could be shown for the level of components of low-density lipoproteins. These and other observations call for reevaluation of relations between particular species of lipoproteins containing apolipoprotein B and the pathogenesis of coronary artery atherosclerosis and coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8252689     DOI: 10.1161/01.cir.88.6.2762

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  24 in total

1.  Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase.

Authors:  M Shimada; S Ishibashi; T Inaba; H Yagyu; K Harada; J I Osuga; K Ohashi; Y Yazaki; N Yamada
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

Review 2.  Is it LDL particle size or number that correlates with risk for cardiovascular disease?

Authors:  H Robert Superko; Radhika R Gadesam
Journal:  Curr Atheroscler Rep       Date:  2008-10       Impact factor: 5.113

3.  Should both HDL-C and LDL-C be targets for lipid therapy? A review of current evidence.

Authors:  B Greg Brown; Xue-Qiao Zhao; Marian C Cheung
Journal:  J Clin Lipidol       Date:  2007-02-15       Impact factor: 4.766

4.  Lipoprotein(a) and SYNTAX Score Association with Severity of Coronary Artery Atherosclerosis in North India.

Authors:  Fauzia Ashfaq; P K Goel; Nagraja Moorthy; Rishi Sethi; Mohammed Idrees Khan; Mohammed Zafar Idris
Journal:  Sultan Qaboos Univ Med J       Date:  2012-11-20

5.  Plasma-derived Extracellular Vesicles Contain Predictive Biomarkers and Potential Therapeutic Targets for Myocardial Ischemic (MI) Injury.

Authors:  Esther Sok Hwee Cheow; Woo Chin Cheng; Chuen Neng Lee; Dominique de Kleijn; Vitaly Sorokin; Siu Kwan Sze
Journal:  Mol Cell Proteomics       Date:  2016-05-27       Impact factor: 5.911

Review 6.  Metabolic complications associated with HIV protease inhibitor therapy.

Authors:  David Nolan
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  Postprandial lipemia is modified by the presence of the APOB-516C/T polymorphism in a healthy Caucasian population.

Authors:  Pablo Pérez-Martínez; Francisco Pérez-Jiménez; José María Ordovás; Juan Antonio Moreno; Carmen Marín; Rafael Moreno; Yolanda Jiménez-Gómez; Juan Antonio Paniagua; José López-Miranda
Journal:  Lipids       Date:  2007-02-10       Impact factor: 1.880

8.  PPARdelta is a very low-density lipoprotein sensor in macrophages.

Authors:  Ajay Chawla; Chih-Hao Lee; Yaacov Barak; Weimin He; John Rosenfeld; Debbie Liao; Jungyeob Han; Heonjoong Kang; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-22       Impact factor: 11.205

9.  Identification of patients at high risk for adverse coronary events while awaiting routine coronary angioplasty.

Authors:  M Chester; L Chen; J C Kaski
Journal:  Br Heart J       Date:  1995-03

10.  Effects of feeding periods of high cholesterol and saturated fat diet on blood biochemistry and hydroxyproline fractions in rabbits.

Authors:  Mohamed A K Abdelhalim; N J Siiddiqi; A S Alhomida; Mohammed S Al-Ayed
Journal:  Bioinform Biol Insights       Date:  2008-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.